Fate Therapeutics Congress Trades
NASDAQ: FATEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Jan 31, 2023
Fate Therapeutics Congress trading summary
Members of Congress have disclosed 1 transaction in Fate Therapeutics (FATE) stock, reported by 1 politician. No FATE trades were reported with a transaction date in the past 12 months. The most active trader is Rep. Daniel S. Goldman (1).
The latest reported trade is a sale by Daniel S. Goldman dated Jan 31, 2023 and disclosed on Feb 24, 2023. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading FATE
FATE trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Daniel S. GoldmanD-NYHouse | Sell | $1,001 – $15,000 | Jan 31, 2023 | Filing for Daniel S. Goldman FATE trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell FATE. How Congress trading data works